Belite Bio, Inc Value Added Tax Receivable, Current
Belite Bio, Inc (BLTE) had Value Added Tax Receivable, Current of $18.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Nontrade Receivables
us-gaap:ValueAddedTaxReceivableCurrent · last filed 2026-03-31
- 2025-12-31: Value Added Tax Receivable, Current $18.00K.
- 2024-12-31: Value Added Tax Receivable, Current $19.00K.
- 2023-12-31: Value Added Tax Receivable, Current $31.00K.
- 2022-12-31: Value Added Tax Receivable, Current $17.00K.
| Period end | Value Added Tax Receivable, Current |
|---|---|
| 2025-12-31 | $18.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | $19.00K 20-F · filed 2026-03-31 |
| 2023-12-31 | $31.00K 20-F · filed 2025-03-17 |
| 2022-12-31 | $17.00K 20-F · filed 2024-03-12 |
| 2021-12-31 | $23.00K 20-F · filed 2023-03-31 |